You are here

Article Text

Article menu
Download PDFPDF
Editorial
Stop advertising
  1. James Cave, Editor-in-Chief
  1. The Downland Practice, Berkshire, UK
  1. Correspondence to Dr James Cave, The Downland Practice, Berkshire, UK; jcave{at}bmj.com

https://doi.org/10.1136/dtb.2022.000046

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In the UK, the promotion and advertising of prescription-only medicines (POMs) is tightly regulated by law with detailed guidance published in the Medicines and Healthcare products Regulatory Agency’s (MHRA) Blue Guide.1 POMs can be promoted to healthcare professionals but must not be advertised to the general public. Any advertisement must present the medicine objectively ‘and without exaggerating its qualities’ and comply with the details listed in the summary of product characteristics. Reference material, factual informative statements or announcements are not considered to be adverts provided that they do not make a product claim and press releases should provide details of those for whom a drug may be suitable using language that is ‘factual and not sensationalised’.1 The guidance also makes it clear that anyone could …

    View Full Text

    Footnotes

    • Competing interests None declared. Refer to the online supplementary files to view the ICMJE form(s).

    • Provenance and peer review Commissioned; externally peer reviewed.